Acucela Inc. intends to develop a medical device to significantly halt or reverse myopic progression, which is a significant public health concern across the world, especially in Asian demographics. Acucela is working towards a spectacle-like device (eSPECs), which will have a clear zone for unimpeded central visual tasks and a periphery that provides defocus in order to alter retinal physiology leading to myopia regulation. This study will establish the changes seen during a proof-of-concept that projected defocus in the periphery utilizing a wearable device will stimulate physiological changes similar to those in the literature.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
26
For the right/test eye, a defocused image is projected onto the peripheral retina while the subject views a distant, in-focus image
For the left/control eye, no image is projected onto the peripheral retina. The subject views a distant, in-focus image.
Manhattan Vision Associates/institute of Vision Research
New York, New York, United States
Axial length (AL)
Change in AL from baseline in the test eye vs. control eye
Time frame: 1 hour
Choroidal thickness (CT)
Change in CT from baseline in the test eye vs. control eye
Time frame: 1 hour
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.